Integrated BioPharma replaces auditor Marcum with CBIZ CPAs after Marcum's attest business acquisition

INTEGRATED BIOPHARMA INC

Marcum LLP resigned as auditor effective April 24, 2025; CBIZ CPAs P.C. engaged for fiscal year ending June 30, 2025.
Marcum's reports for FY 2024 and 2023 were unqualified, with no adverse opinions or modifications.
No disagreements or reportable events between the Company and Marcum during the past two fiscal years and interim period.
No prior consultations with CBIZ CPAs regarding accounting principles, audit opinions, or reportable events.
Change approved by Audit Committee; Marcum provided a letter to the SEC agreeing with the disclosures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.